Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis

BRYANT HENRY U, CULLINAN George J., DODGE JEFFREY A, FAHEY KENNAN J, JONES Charles D., LUGAR CHARLES W, MUEHL BRIAN S
1996
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-09-17 ⓘ

The patent discloses specific naphthly compounds and their pharmaceutically acceptable salts for the inhibition of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The present invention provides a compound of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2 (C4-C6 alkyl); R2 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl) or -OSO2 (C4-C6 alkyl); n is 2 or 3; and R3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof, for inhibiting endometriosis.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-17T06:14:45.765109+00:00